| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.4M | -57.0% |
| Cost of Revenue | $15.1M | -36.1% |
| Gross Profit | -$751K | -107.7% |
| R&D Expense | $586K | -59.4% |
| SG&A Expense | $3.1M | -17.1% |
| Operating Income | -$14.6M | -21.4% |
| Net Income | -$11.0M | -53.6% |
| EPS (Basic) | -$1.10 | -44.7% |
| EPS (Diluted) | -$1.10 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.5M | -54.6% |
| Short-term Investments | $4.5M | +0.0% |
| Accounts Receivable | $80K | +0.0% |
| Inventory | $2.5M | -48.5% |
| Current Assets | $10.4M | -60.9% |
| Total Assets | $25.9M | -35.0% |
| Current Liabilities | $3.7M | -11.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -0.6% |
| Capital Expenditures | $6.3M | +22.8% |
| Investing Cash Flow | -$1.9M | +71.9% |
| Financing Cash Flow | -$214K | -103.1% |
| Free Cash Flow | -$13.3M | -10.1% |
| -44.7% |
| Long-term Debt |
| $500K |
| +0.0% |
| Total Liabilities | $6.7M | -14.4% |
| Stockholders' Equity | $19.2M | -18.3% |